Vg Life Sciences Stock Net Income
| VGLS Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of Vg Life Sciences, as well as the relationship between them.
Vg Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Vg Life's valuation are provided below:Vg Life Sciences does not today have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. VGLS |
Vg Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vg Life's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vg Life.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in Vg Life on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Vg Life Sciences or generate 0.0% return on investment in Vg Life over 90 days. Vg Life is related to or competes with Ayala Pharmaceuticals. VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for comba... More
Vg Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vg Life's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vg Life Sciences upside and downside potential and time the market with a certain degree of confidence.
Vg Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vg Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vg Life's standard deviation. In reality, there are many statistical measures that can use Vg Life historical prices to predict the future Vg Life's volatility.Vg Life Sciences Backtested Returns
Vg Life is out of control given 3 months investment horizon. Vg Life Sciences retains Efficiency (Sharpe Ratio) of 0.26, which indicates the firm had a 0.26 % return per unit of price deviation over the last 3 months. We were able to break down and interpolate six different technical indicators, which can help you to evaluate if expected returns of 72.58% are justified by taking the suggested risk. Use Vg Life Sciences Daily Balance Of Power of 9.2 T, price action indicator of 1.0E-4, and Day Median Price of 1.0E-4 to evaluate company specific risk that cannot be diversified away. Vg Life holds a performance score of 20 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vg Life are completely uncorrelated. Use Vg Life Sciences daily balance of power , to analyze future returns on Vg Life Sciences.
Auto-correlation | 0.29 |
Poor predictability
Vg Life Sciences has poor predictability. Overlapping area represents the amount of predictability between Vg Life time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vg Life Sciences price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Vg Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Vg Life Sciences reported net income of (6.19 Million). This is 101.81% lower than that of the Biotechnology sector and 108.84% lower than that of the Health Care industry. The net income for all United States stocks is 101.08% higher than that of the company.
VGLS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vg Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vg Life could also be used in its relative valuation, which is a method of valuing Vg Life by comparing valuation metrics of similar companies.Vg Life is currently under evaluation in net income category among its peers.
VGLS Fundamentals
| Return On Asset | -1.51 | |||
| Current Valuation | 4.44 M | |||
| Shares Outstanding | 107.88 M | |||
| Price To Earning | (0.14) X | |||
| Price To Book | 32.38 X | |||
| EBITDA | (3.43 M) | |||
| Net Income | (6.19 M) | |||
| Cash And Equivalents | 22.92 K | |||
| Total Debt | 3.38 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.91 M) | |||
| Earnings Per Share | (0.07) X | |||
| Target Price | 0.15 | |||
| Beta | 2.76 | |||
| Market Capitalization | 1.82 M | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (109.84 M) | |||
| Working Capital | (5.42 M) | |||
| Current Asset | 40 K | |||
| Current Liabilities | 5.46 M | |||
| Net Asset | 1.32 M |
About Vg Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vg Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vg Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vg Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.